Skip to content

Clinical trials

Phase 3 Immune System Diseases trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Immune System Diseases Phase: Phase 3 Country / region: Mexico Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20151
20161
20183
20222
20234
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Active, not recruiting5
Enrolling by invitation2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Viatris Innovation GmbH3
AstraZeneca2
Bristol-Myers Squibb2
Pfizer2
Baxalta now part of Shire1
Biogen1
Eli Lilly and Company1
Instituto Nacional de Perinatologia Isidro Espinosa de los Reyes1
La Jolla Pharmaceutical Company1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Immune System Diseases15
Autoimmune Diseases10
Connective Tissue Diseases8
Lupus Erythematosus, Systemic8
Dermatitis2
Dermatitis, Atopic2
Eczema2
Genetic Diseases, Inborn2
Hypersensitivity2
Hypersensitivity, Immediate2

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.